- Service Name
Gene Writing™
- Industry
Biotechnology, Genetic Medicine, Genome Engineering, Therapeutics
- Main Value Proposition
The primary value offered is the ability to cure diseases by directly writing therapeutic information into the human genome, thus treating conditions at their genetic source.
- Description
Tessera Therapeutics is pioneering Gene Writing™, a groundbreaking genome engineering technology that enables the writing of therapeutic messages into the genome to address diseases at their source. This innovative approach aims to provide potentially curative and accessible therapies for major unmet medical needs.
- Key Features
Versatile technology platform for genome alterations; Tissue-targeted non-viral delivery technology; Ability to make both small and large alterations to the genome; Focus on addressing major unmet medical needs
- Use Cases
Gene Writing™ is most valuable in scenarios where genetic diseases need to be treated at their source, such as in conditions like sickle cell disease and other genetic disorders.
- Competitive advantages
First-of-its-kind technology in the field of genetic medicine; Ability to make permanent alterations to the genome; Focus on tissue-targeted delivery, enhancing treatment efficacy
- Strengths
Tessera Therapeutics leverages cutting-edge technology in gene writing, a strong mission to cure diseases, and a commitment to addressing significant medical needs, which positions it as a leader in the biotechnology sector.
- Positioning
Tessera Therapeutics positions itself as a pioneering leader in the biotechnology industry, focusing on innovative solutions for genetic medicine that aim to transform treatment paradigms.
- Audience
The target users include scientists and medical professionals looking for innovative solutions in genetic medicine, patients with genetic diseases, and investors interested in pioneering biotechnology.
- Brand Positioning
The brand identity is centered around innovation and leadership in genetic medicine, emphasizing its role as a flagship company in the biotechnology sector.
- CTA
Learn more about Gene Writing™
- Differentiation
Gene Writing™ is unique as it represents a new category of genetic medicine that combines advanced genome engineering with a focus on therapeutic applications, setting it apart from traditional gene therapy methods.
- Tagline
Pioneering Gene Writing
- Tags
genetic medicine
biotechnology
gene therapy
genome engineering
- Tone of Voice
Innovative, authoritative, optimistic
- Founded
2018-01-01
- Founders
Geoffrey von Maltzahn
Jacob Rubens
Noubar Afeyan